BackRubius Therapeutics Overview

Rubius Therapeutics Short-Term Investments

Latest short-term investments for RUBY: $4.1M.

Get informed when a big investor buys or sells

+ Follow
Short-Term Investments
$4.07M

Peer trimmed avg / median

Loading

Rubius Therapeutics Short-Term Investments History

Loading

Rubius Therapeutics vs. peers: Short-Term Investments Comparison

Loading

Rubius Therapeutics Short-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Rubius Therapeutics (RUBY) FAQ

Rubius Therapeutics (RUBY) currently reports a short-term investments of $4.1M as of December 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Rubius Therapeutics's short-term investments history and peer comparisons.

Rubius Therapeutics's short-term investments changed from $0 to $4.1M (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rubius Therapeutics reported $4.1M in short-term investments as of December 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current short-term investments of $4.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rubius Therapeutics, and consider following RUBY for alerts when major investors trade the stock.

Rubius Therapeutics is classified in the Healthcare sector. On short-term investments, it currently shows $4.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RUBY with unrelated industries.